Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023
Period Ending	Apr 30, 2024	Apr 30, 2023
Cash & Equivalents	0.09	0.02
Cash & Short-Term Investments	0.09	0.02
Cash Growth	398.02%	-
Prepaid Expenses	0.01	-
Total Current Assets	0.1	0.02
Total Assets	0.1	0.02
Accounts Payable	0.06	-
Total Current Liabilities	0.06	-
Total Liabilities	0.06	-
Common Stock	0.1	0
Retained Earnings	-0.06	-0
Comprehensive Income & Other	-	0.02
Shareholders' Equity	0.03	0.02
Total Liabilities & Equity	0.1	0.02
Net Cash (Debt)	0.09	0.02
Net Cash Growth	398.02%	-
Net Cash Per Share	0.19	-
Filing Date Shares Outstanding	38.38	-
Total Common Shares Outstanding	4.38	-
Working Capital	0.03	0.02
Book Value Per Share	0.01	-
Tangible Book Value	0.03	0.02
Tangible Book Value Per Share	0.01	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.